Life Sciences Overview

  • Companies
  • 39,732

  • Deals
  • 127,959

  • Investors
  • 39,306

  • Exits
  • 22,543

  • Largest Deal

  • Capital Invested

  • Median Post Valuation

Description

Companies involved in sciences dealing with living organisms and life processes, including biology, pharmaceuticals, biomedical technology and nutraceuticals. To learn more about the 50+ industries PitchBook tracks on the platform, visit our industry verticals page.

Using PitchBook’s advanced search capabilities and in-depth industry data, clients can search top Life Sciences startups, companies, investors, and acquirers. Track recent Life Sciences deals and IPOs, funding history and key participants in the M&A process. Discover new investment opportunities, industry trends and insights with research curated by our world-class analysts.

Life Sciences Companies to watch

This list of life sciences companies identifies life sciences startups and companies with high growth potential based on factors such as capital raised and number of funding rounds. Using our list of life sciences startups, our users can pinpoint companies that are likely fundraising based on recent activity in seed or early-stage funding rounds.

  • AbogenBio

    Last Deal Type

    Series C1

    Last Post Valuation

  • Probio Technology

    Last Deal Type

    Series C

    Last Post Valuation

  • Viridos

    Last Deal Type

    Series A

    Last Post Valuation

  • Valo

    Last Deal Type

    Series C

    Last Post Valuation

  • Belief BioMed

    Last Deal Type

    Series C

    Last Post Valuation

  • Asimov

    Last Deal Type

    Series B

    Last Post Valuation

  • AcornMed

    Last Deal Type

    Series B

    Last Post Valuation

  • Immunai

    Last Deal Type

    Series B

    Last Post Valuation

  • Cheerland

    Last Deal Type

    Series B

    Last Post Valuation

  • JOINN Biologics

    Last Deal Type

    Series B1

    Last Post Valuation

Top private and public life sciences companies

This list identifies life sciences companies with some of the highest valuations and market caps respectively.

Private life sciences companies

Company Name Last Post Valuation Last Deal Type
Global Life Sciences Solutions USA Grant
Biosplice Therapeutics 2ndary - Private
Colossal Laboratories & Biosciences Series C
Ceva Sante Animale PE Growth
Resilience (Biotechnology) Grant

Public life sciences companies

Company Name Stock Price Market Cap
Eli Lilly (NYS: LLY) $705B
AbbVie (NYS: ABBV) $328B
Roche (SWX: ROG) $255B
Abbott (NYS: ABT) $230B
Novartis (SWX: NOVN) $230B
To view a full list of Life Sciences private and public companies, request access »

Want detailed data on 50+ industry verticals?

What you see here scratches the surface

Request a free trial

Want to dig into this industry profile?

We’ll help you find what you need

Learn more

Top life sciences investors and acquirers

This list showcases some of the most active investors and acquirers in life sciences.

Investor Name Number of Investments Last Investment Size
U.S. Department of Health and Human Services 1,779
U. S. National Science Foundation 1,142
Innovate UK 1,090
National Institutes of Health 963
OrbiMed 666
To view a full list of Life Sciences investors and acquirers, request access »

Life Sciences Investments over time

This chart shows life sciences investment trends for different types of deals over time. Use it to understand the growth and changes of the deal landscape of the companies you are interested in.

Life Sciences Market Map

Information technology

Healthcare

Business products and services (B2B)

Life Sciences Acquisitions over time

Life Sciences IPOs over time

Life Sciences Industry growth

This chart compares the median post valuation and median deal size for companies in this industry.

Life Sciences Company count breakdown by geography

Life Sciences FAQs